Integrated DNA Technologies, Inc. (a subsidiary of Danaher), Thermo Fisher Scientific Inc. and Merck KGaA are Dominating the Global Gene Synthesis Market in 2020

Global Gene Synthesis Market is expected to grow with the CAGR of 27.0% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-gene-synthesis-market

Global gene synthesis market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.

The major players dealing in global gene synthesis market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced product portfolio.

For instance:

  • In December 2017 Integrated DNA Technologies, Inc. (a subsidiary of Danaher) had acquired GeneWorks Pty Ltd in Australia. The company has acquired this company to accelerate the manufacturing of oligonucleotides used for gene synthesis, among other purposes. This acquisition had accelerated the company’s manufacturing abilities and helped fulfill the unmet customers demand dealing with the gene synthesis market.

Integrated DNA Technologies, Inc. (a subsidiary of Danaher) is the dominating player in global gene synthesis market. The other key players existing in the market are Bio Basic Inc., Twist Bioscience, ATG:biosynthetics GmbH, BioCat GmbH, Aldevron, Eurofins Scientific, exonbio, bbi-lifesciences, Creative Biogene, trenzyme GmbH, Thermo Fisher Scientific Inc., Merck KGaA, Kaneka Eurogentec S.A., LGC Limited, Codex DNA, Inc., ATUM, GenScript, GENEWIZ (a subsidiary of Brooks Automation, Inc.), Evonetix among others.

Gene Synthesis Market

Integrated DNA Technologies, Inc. (a subsidiary of Danaher)

Integrated DNA Technologies, Inc. (a subsidiary of Danaher) headquarter is in Iowa, U.S. The company is focused on the development and manufacturing of nucleic acid products that support the life sciences industry. The company has several product & service categories including COVID-19 solutions, qPCR & PCR, DNA & RNA, CRISPR genome editing, genes & gene fragments, functional genomics, next generation sequencing, reagents & kits in which genes & gene fragments is the market focused category.

For instance,

  • In June 2020, Integrated DNA Technologies, Inc. (a subsidiary of Danaher) launched gBlocks HiFi Gene Fragment which helped researchers to build large gene constructs and avoid unwanted errors including frequent mutations in the gene sequences. This product launch boosted the company’s product portfolio and helped it penetrate its root in the global gene synthesis market.

The company has wide presence across Americas, Asia-Pacific, Europe, Middle East and Africa. The company also has various subsidiary companies including Mbiotech, Inc. (South Korea), Integrated Dna Technologies Pte. Ltd. (U.S.), Swift Biosciences Inc. (U.S.), Integrated Dna Technologies Spain Sl (Spain), GenBase, Inc. (U.S.) among others.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc., founded in the year 1956, headquarter in Massachusetts, U.S. Their main focus of the company is on making the world healthier, cleaner and safer by enabling their customers and supports them in improving patient’s therapies and diagnostics. The comp any operates its business via several business segments including life sciences solutions, analytical instruments, specialty diagnostics and laboratory products and services in which life science solutions is the market focused segment. The company has two product categories which are application and techniques in which techniques is the market focused category.

For instance,

  • In February 2021, Thermo Fisher Scientific Inc. had acquired the Mesa Biotech, the company which has developed the PCR-based testing platform for infectious disease diagnosis. This system launched provides with efficient and accurate result in less span of time. The product launched carries out the gene synthesis in order to confirm the nucleic acid molecule of pathogenic organism. This acquisition thus allowed Thermo Fisher Scientific Inc. to leverage its existing product portfolio and to expand its root in gene synthesis market.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, North America. The company also has various subsidiaries including Thermo Informatics Asia Pacific Pty Ltd.(TORRENVILLES PLAZA, SA,), Thermo Gamma-Metrics Holdings Pty Ltd.( victoria, Australia), Thermo Electron LED S.A.S. (Hessen, Germany), Thermo Trace Ltd.(victoria, Australia) Thermo Finnigan Australia Pty. Ltd. (NSW, Australia) among others.

Merck KGaA

Merck KGaA founded in the year 1668, headquarter in Darmstadt, Germany. The main focus of the company is to drive towards their purpose by making progress in technologies that benefits all human lives by providing them their research and products. The company operates its business via several business segments including life science, healthcare and electronics in which life science is the market focused segment. The company has two product categories which are product & services and science & technology in which product & services is the market focused category.

For instance,

  • In In April 2020, Merck KGaA announced that they would be launching 100 million euros worth commercial facility for its BioReliance viral and gene therapy services by the next year, 2021 so as to achieve major advancements in medicine. As the company is constantly focused on manufacturing of reagents among others used in the field of genomic, this expansion helped the company to accelerate the growth of gene therapy services which is greatly dependent upon gene synthesis.

The company has presence across Asia-Pacific, Europe, Middle East and Africa, South America, North America. The company also has various subsidiaries including AZ Electronic Materials (Luxembourg), Merck Serono (Darmstadt, Germany), Merck Millipore(Burlington, U.S.), Serono, Sigma-Aldrich (Munich, Germany), Carbolabs and Versum Materials (Arizona, U.S.) among others.